ArticlePloS one2026
Prevalence and prognostic impact of unrecognized myocardial infarction detected by cardiac magnetic resonance in Thai patients with obesity.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUnrecognized myocardial infarction (UMI) is associated with adverse outcomes and may occur in patients with obesity, who are at increased cardiovascular risk. Although cardiac magnetic resonance (CMR) enables accurate detection of UMI, prognostic data in patients with obesity remain limited, particularly in Asian populations. This study evaluated the prevalence and prognostic impact of CMR-detected UMI in Thai patients with obesity.
methodsThis cohort study included 1,053 patients with BMI ≥ 25 kg/m2, without a prior diagnosis of myocardial infarction (MI) or coronary revascularization (mean age, 67 ± 11 years; 71.3% grade 1 and 28.7% grade 2 obesity), who underwent CMR at an academic hospital in Thailand between 2014 and 2016. The most common indication was suspected coronary artery disease (78.3%). UMI was identified using late gadolinium enhancement imaging. Patients were followed for major adverse cardiovascular events (MACE), defined as a composite of cardiovascular death, nonfatal MI, or hospitalization for heart failure.
resultsUMI was identified in 105 patients (9.9%). During a median follow-up of 9.2 (5.2-10.2) years, patients with UMI had a significantly higher rate of MACE compared with those without UMI (2.58 vs. 0.89 per 100 patient-years; HR, 2.86; 95% CI, 1.68-4.88; p < 0.001). In multivariable analysis, age, diabetes, cigarette smoking, history of heart failure, LVEF, and UMI were independently associated with MACE. The presence of UMI provided incremental prognostic value beyond traditional risk factors (Δχ2 = 22.43; p < 0.001). Across all subgroups defined by age, sex, obesity grade, diabetes status, symptoms, LVEF, and myocardial ischemia, UMI was consistently associated with higher risks of MACE, with no significant interactions observed (all p for interaction>0.05).
conclusionsIn Thai patients with obesity undergoing CMR, the prevalence of UMI was 9.9% and was independently associated with MACE, providing incremental prognostic value. These findings suggest that CMR-detected UMI may play a role in risk stratification in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.